Human amniotic membrane-derived device company MiMedx Group, Inc., has announced that its Board of Directors has appointed two new members, effective September 5, 2012. The new directors are healthcare executive Charles R. Evans and Neil S. Yeston, M.D., F.A.C.S., a healthcare practitioner, innovator and leader.
Regenerative Medicine
Kensey Nash Is To Be Acquired by Life And Materials Science Company DSM
We didn’t see this one coming. Royal DSM, which describes itself as a life sciences and material sciences company, sees a great strategic fit with regenerative medicine specialist Kensey Nash, which has encouraged the Dutch based outfit to stump up a number well ahead of the current share price.
Tissue Regenix Seeks Funding For Expansion Programme
UK regenerative medicine company Tissue Regenix has announced bold expansion plans for its operations.
Tissue Regenix’s University Partner wins Queen’s Anniversary Prize
Tissue Regenix’s University Partner (The Institute of Medical and Biological Engineering at Leeds University) has been awarded Queen’s Anniversary Prize, the highest accolade for an academic institution.
Tengion Organ Regeneration Platform Technology Demonstrates Ability to Regenerate Small Intestine in Preclinical Models; Data Published in Regenerative Medicine
Smooth Muscle Cells and Tengion’s Proprietary Biological Scaffolding Spurs Small Intestine Regeneration as Early as Eight Weeks After Implantation.